Antitumor activity of polysaccharide TC-13 extracted from rare actinomycetes.
The antitumor activities of mycelia and a hot-water extract of mycelia of rare actinomycetes were examined by three different antitumor assays in ddY mice with Ehrlich solid tumor. A new antitumor polysaccharide, TC-13, was prepared from the hot-water extract of Microellobosporia grisea by precipitation with cetylpyridinium chlorideborate complex and gel filtration. TC-13 was mainly composed of glucose and mannose with peptideglycan. Its molecular weight was determined to be 2-30 X 10(4) by gel filtration. Comparative studies suggested that the antitumor activity of TC-13 was equal to, or stronger than those of other antitumor agents (e.g., lentinan, PS-K, OK432 and yeast mannan). Screening methods for antitumor activity of actinomycetes were also discussed.[1]References
- Antitumor activity of polysaccharide TC-13 extracted from rare actinomycetes. Kohno, M., Abe, S., Sato, K., Yamazaki, M., Mizuno, D. Jpn. J. Exp. Med. (1983) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
